Ottawa startup announced this week it’s landed $400,000 in federal government funding to help the National Research Council of Canada develop a gene therapy to treat lipoprotein lipase deficiency.
Ottawa firm inks deal to help Oxford Biomedica improve the yield and production efficiency of its next-generation gene therapies.
Company's revenues have more than doubled in the past year, and CEO expects headcount to grow from 16 to at least 30 by next year as demand for its products ramps up.
Multimillionaire Gatineau businessman Olivier Benloulou has become a significant investor and trusted adviser as young firm looks to crack retail market in 2022.
Local biotech firm's groundbreaking platform is used by medical researchers around the world to create 3D images of hearts, knees and other body parts.
Local firm's system uses a concept called fogponics, a technique pioneered by NASA that nourishes plants with nutrient-enriched water vapour.
Company announced this week that Health Canada has given the green light to its device for emergency use, meaning labs now have access to the spit kit for COVID-19 testing.
Ottawa company says it plans to begin shipping the device “immediately” to federal and provincial governments as well as commercial customers.
Local economic development agencies are doing their best to help give the city’s fledgling biotech and medical devices sector a leg up
Finding investors willing to play the long game can be a challenge